CIM LLC’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,632	Closed	-$279K	–	112
2018 Q3	$279K	Sell	1,632 -35	-2%	-$5.98K	0.1%	94
2018 Q2	$215K	Buy	+1,667	New	+$215K	0.08%	103